Addenda Capital Inc. Purchases 2,073 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Addenda Capital Inc. lifted its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 8.6% during the 4th quarter, Holdings Channel reports. The firm owned 26,234 shares of the healthcare conglomerate’s stock after acquiring an additional 2,073 shares during the period. Addenda Capital Inc.’s holdings in UnitedHealth Group were worth $13,811,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Moneta Group Investment Advisors LLC lifted its stake in UnitedHealth Group by 100,076.4% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after acquiring an additional 11,812,017 shares during the period. Norges Bank purchased a new stake in UnitedHealth Group in the fourth quarter worth $5,210,004,000. Arrowstreet Capital Limited Partnership lifted its position in UnitedHealth Group by 1,682.4% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after buying an additional 2,540,538 shares during the period. Barclays PLC lifted its position in UnitedHealth Group by 143.4% during the second quarter. Barclays PLC now owns 3,494,100 shares of the healthcare conglomerate’s stock valued at $1,679,401,000 after buying an additional 2,058,829 shares during the period. Finally, Morgan Stanley lifted its position in UnitedHealth Group by 13.8% during the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock valued at $8,289,386,000 after buying an additional 1,893,192 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE UNH opened at $458.16 on Wednesday. UnitedHealth Group Incorporated has a 52 week low of $445.68 and a 52 week high of $554.70. The firm has a market capitalization of $422.39 billion, a P/E ratio of 19.22, a PEG ratio of 1.33 and a beta of 0.54. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. The company has a 50-day moving average price of $500.89 and a 200-day moving average price of $518.93.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating the consensus estimate of $5.98 by $0.18. The firm had revenue of $94.43 billion during the quarter, compared to analyst estimates of $92.13 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The business’s revenue for the quarter was up 14.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $5.34 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.64%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.54%.

Analyst Ratings Changes

UNH has been the subject of several recent research reports. Piper Sandler lowered their price objective on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a research report on Wednesday, January 17th. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a report on Friday, January 19th. Bank of America restated a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Royal Bank of Canada restated an “outperform” rating and set a $596.00 price target on shares of UnitedHealth Group in a report on Thursday, February 29th. Finally, Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $579.33.

View Our Latest Research Report on UNH

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.